In breast cancer, focal MYC amplification is relatively rare (~6% in The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium cohorts), whereas arm-level amplification of 8q is common (~50%). Here, MYC is linked to breast cancer.